Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer
Harry B Lengel, Junting Zheng, Kay See Tan, et al.
The Lancet. Oncology
|
May 6, 2024
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
Bob T Li, Funda Meric-Bernstam, Aditya Bardia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 11, 2021
Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma
Daniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.
The Oncologist
|
June 20, 2020
ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling
Malinda Itchins, Brandon Lau, Amanda L Hudson, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
JTO Clinical and Research Reports
|
September 23, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
Malinda Itchins, Shirley Liang, Chris Brown, et al.
NPJ Breast Cancer
|
January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy
Luc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Chest
|
March 22, 2021
Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm
Run-Bin Liang, Peng Li, Bob T Li, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 2, 2023
Lung resection after initial nonoperative treatment for non-small cell lung cancer
Elizabeth G Dunne, Cameron N Fick, Kay See Tan, et al.
JCO Precision Oncology
|
July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study
Lillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Thoracic and Cardiovascular Surgery
|
December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer
Harry B Lengel, Junting Zheng, Kay See Tan, et al.
The Lancet. Oncology
|
May 6, 2024
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
Bob T Li, Funda Meric-Bernstam, Aditya Bardia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 11, 2021
Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma
Daniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.
The Oncologist
|
June 20, 2020
ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling
Malinda Itchins, Brandon Lau, Amanda L Hudson, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
JTO Clinical and Research Reports
|
September 23, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
Malinda Itchins, Shirley Liang, Chris Brown, et al.
NPJ Breast Cancer
|
January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy
Luc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Chest
|
March 22, 2021
Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm
Run-Bin Liang, Peng Li, Bob T Li, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 2, 2023
Lung resection after initial nonoperative treatment for non-small cell lung cancer
Elizabeth G Dunne, Cameron N Fick, Kay See Tan, et al.
JCO Precision Oncology
|
July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study
Lillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
Page
of 14